T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Saic
SAIC
$5.34B
| $22.3M | ﹤0.01% |
266,310
-213,592
| -45% | -$20M |
|
1252
Williams-Sonoma
WSM
$28.6B
| $22.1M | ﹤0.01% |
246,420
-8,108
| -3% | -$547K |
|
1253
Lumentum
LITE
$83.2B
| $22.1M | ﹤0.01% |
241,473
-42,154
| -15% | -$3.9M |
|
1254
SEACOR Marine Holdings
SMHI
$266M
| $22M | ﹤0.01% |
4,132,015
-11,020
| -0.3% | -$44.8K |
|
|
CMIIU
1255
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| $21.8M | ﹤0.01% |
+1,703,300
| New | +$21.4M |
|
1256
Lumen
LUMN
$6.76B
| $21.8M | ﹤0.01% |
1,632,501
-54,173
| -3% | -$673K |
|
1257
Alliant Energy
LNT
$18.2B
| $21.7M | ﹤0.01% |
400,897
-19,245
| -5% | -$957K |
|
|
USX
1258
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $21.4M | ﹤0.01% |
1,820,368
-269,736
| -13% | -$2.48M |
|
1259
Hormel Foods
HRL
$13.5B
| $21.3M | ﹤0.01% |
446,737
-47,394
| -10% | -$2.24M |
|
1260
IDEAYA Biosciences
IDYA
$3.47B
| $21.2M | ﹤0.01% |
900,265
+429,166
| +91% | +$8.29M |
|
1261
Schrodinger
SDGR
$1.33B
| $21.1M | ﹤0.01% |
276,480
-380,213
| -58% | -$34.2M |
|
1262
Dine Brands
DIN
$434M
| $21M | ﹤0.01% |
233,053
+219,908
| +1,673% | +$17.1M |
|
1263
UDR
UDR
$12.2B
| $20.9M | ﹤0.01% |
476,223
-29,298
| -6% | -$1.21M |
|
1264
Abercrombie & Fitch
ANF
$4.8B
| $20.8M | ﹤0.01% |
606,919
+567,066
| +1,423% | +$15.6M |
|
1265
Ameris Bancorp
ABCB
$6.04B
| $20.8M | ﹤0.01% |
395,645
+38,953
| +11% | +$1.85M |
|
1266
Kinross Gold
KGC
$32.7B
| $20.8M | ﹤0.01% |
3,118,113
+525,288
| +20% | +$3.65M |
|
|
AMRS
1267
DELISTED
Amyris Inc.
AMRS
| $20.6M | ﹤0.01% |
1,079,123
+1,019,968
| +1,724% | +$14.8M |
|
|
FOLD
1268
DELISTED
Amicus Therapeutics
FOLD
| $20.6M | ﹤0.01% |
2,085,672
+36,310
| +2% | +$562K |
|
1269
Hasbro
HAS
$13.7B
| $20.6M | ﹤0.01% |
214,216
-16,146
| -7% | -$1.53M |
|
1270
Quanta Services
PWR
$103B
| $20.3M | ﹤0.01% |
230,291
-12,674
| -5% | -$1.01M |
|
|
KNTE
1271
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $20.2M | ﹤0.01% |
648,782
-624
| -0.1% | -$21.7K |
|
1272
Iron Mountain
IRM
$37.7B
| $20.1M | ﹤0.01% |
542,821
-52,235
| -9% | -$1.75M |
|
1273
LKQ Corp
LKQ
$6.44B
| $20M | ﹤0.01% |
473,535
-34,207
| -7% | -$1.35M |
|
1274
F5
FFIV
$23.3B
| $19.9M | ﹤0.01% |
95,410
-6,444
| -6% | -$1.27M |
|
1275
Advance Auto Parts
AAP
$3.38B
| $19.9M | ﹤0.01% |
108,238
-11,096
| -9% | -$1.86M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.